Refinement of breast cancer classification by molecular characterization of histological special types.
about
Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumoursBiomarkers in triple negative breast cancer: A reviewBreast Cancer: Conventional Diagnosis and Treatment Modalities and Recent Patents and TechnologiesTriple-negative breast cancer: is there a treatment on the horizon?Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB familyA Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates from the 3rd EditionPhenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancerBreast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications.A resampling-based meta-analysis for detection of differential gene expression in breast cancerA taxonomy of epithelial human cancer and their metastases.Next-generation sequencing.Unraveling breast cancer heterogeneity through transcriptomic and epigenomic analysis.β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breast.HER2 in Breast Cancer Stemness: A Negative Feedback Loop towards Trastuzumab Resistance.Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.The invasive lobular carcinoma as a prototype luminal A breast cancer: a retrospective cohort study.Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets.Molecular genetics complexity impeding research progress in breast and ovarian cancers.Polarity gene alterations in pure invasive micropapillary carcinomas of the breastTriple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants.Rare breast cancer subtypes: histological, molecular, and clinical peculiaritiesGross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypesBreast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer.Deconstructing the molecular portraits of breast cancer.Search for neuro-endocrine markers (chromogranin A, synaptophysin and VGF) in breast cancers. An integrated approach using immunohistochemistry and gene expression profiling.Adenoid cystic carcinoma of the breast in the United States (1977 to 2006): a population-based cohort studyBreast cancer genomes--form and functionInvasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17.Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry.E-cadherin promotor methylation and mutation are inversely related to motility capacity of breast cancer cells.Inactivation of p53 in breast cancers correlates with stem cell transcriptional signatures.Malignant adenomyoepithelioma combined with adenoid cystic carcinoma of the breast: a case report and literature review.Absence of microsatellite instability in mucinous carcinomas of the breast.Characteristics of triple-negative breast cancerDecoding Intratumoral Heterogeneity of Breast Cancer by Multiparametric In Vivo Imaging: A Translational Study.Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.Adenoid cystic carcinoma of breast: Recent advances.Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreementExpression of MAGE-A and NY-ESO-1 cancer/testis antigens in medullary breast cancer: retrospective immunohistochemical studyTriple-negative breast cancer: new perspectives for targeted therapies.
P2860
Q21030553-233B0F68-6473-4C62-A428-3F72AB53A2E0Q26775094-1F442F58-FA13-4196-AEED-D5B09693BC24Q26783705-A0E33E1F-815B-4BEA-8551-4D036FE59970Q28077243-B0F49AD3-E718-4113-92BC-D1458E091866Q28258227-48A124BD-EC8F-42C5-B2FE-217DC67EB3A0Q28305715-C6841E35-D03F-48CF-A93D-9E797DCCD537Q29619481-288EB312-7E9F-430B-A4D7-4F04368FD75FQ30245184-C07EE556-1C44-4042-818C-45ED5B8AE4DCQ33396580-4CD4AEB0-A6EB-4D71-8E9B-F6E67EF999D4Q33519183-BEF1E8D3-DEB9-4306-810C-43FA288B1FB4Q33555502-62084430-0BD4-47FA-9E19-2776444FBC4AQ33570282-5C4DBFE0-EDBC-401D-8849-1C2C61FC0797Q33652448-56939596-54B6-466C-AFF2-18ADDFA35C92Q33737278-DA4707BE-D27D-4A15-BFE9-6552AA704C25Q33739841-734124A5-3C24-4AAA-9E17-07899FB86930Q33761874-0ADA124A-5C99-4E00-ADAC-60D2DC3B987CQ33780945-A947AA82-1BDD-47C1-91F0-8DB9D3EE0D27Q33858073-5436A8DE-49BC-4D7E-A02B-3B65C24AFEDAQ33892823-8182C0D9-16B8-4847-9674-6FCE379EA4B5Q33915057-F4FC735C-0449-4758-9859-3EF5B07A6C29Q34005143-46DFAF72-961D-4785-A83F-A70DA53C7928Q34006749-F35EC742-E3D4-423F-A5C3-367093429702Q34083767-494C74BD-A552-41C9-B7F5-3B28A85D4B21Q34154147-1F3942A9-F401-4E6A-924A-A35658DDF61FQ34161862-38A67AB6-6C8C-4B04-BD89-39D1A7039750Q34173479-24018DAD-20EE-464D-AC97-2356EFAA69F8Q34207688-1344F808-043D-4E46-A1BE-83961A8E1B0BQ34392810-E647A7E2-2A04-4A3E-836A-A0DB3AEB044AQ34423470-6BC1EF79-7E63-4652-910D-24D2ACE555B4Q34440049-F3477E9A-E0CB-4FA1-8BDC-7D4880391767Q34449969-AB25D3EC-8344-4D10-A857-F7A8122ACAB1Q34464783-4ECE0CC9-FD05-4B90-BCD9-F99D15F6A0C0Q34467216-75A786A3-F64B-470A-B09A-E152F4131341Q34479003-BF5D0CE8-EB14-4566-A2AF-02612559C606Q34535601-84AFFB51-07B7-422F-9BA3-71CE359029DBQ34556770-D6F2AF1D-3A33-41C1-BE56-DCEC9A9406D3Q34706019-FEA1E24F-680E-48CB-8485-0CA919DFA72BQ34820314-37BADD86-12F9-41A6-B6A1-FC0F30CC1722Q34839826-A6B83BAF-185C-40F1-9331-F3AA442344B3Q35001758-C49A3B5D-C366-40E3-87CB-7AA446956BAC
P2860
Refinement of breast cancer classification by molecular characterization of histological special types.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Refinement of breast cancer cl ...... of histological special types.
@en
Refinement of breast cancer cl ...... of histological special types.
@nl
type
label
Refinement of breast cancer cl ...... of histological special types.
@en
Refinement of breast cancer cl ...... of histological special types.
@nl
prefLabel
Refinement of breast cancer cl ...... of histological special types.
@en
Refinement of breast cancer cl ...... of histological special types.
@nl
P2093
P356
P1476
Refinement of breast cancer cl ...... of histological special types.
@en
P2093
H M Horlings
J L Peterse
L F A Wessels
L J Van't Veer
M J Van de Vijver
P2860
P304
P356
10.1002/PATH.2407
P577
2008-10-01T00:00:00Z